Change and growth in our health care system are driven not only by federal and state regulations and legislation but also by private sector entrepreneurs who strive to expand choice, identify new treatments, and develop cures.
This Hill letter was sent to the Members of the U.S. House of Representatives, opposing H.R. 3, the "Lower Drug Costs Now Act." This bill is on the Legislative Leadership list for the “How They Voted” scorecard.
Learn more about the U.S.-Israel Business Council's bilateral health innovation dialogue.
WASHINGTON, D.C. - The U.S. Chamber of Commerce strongly opposes H.R. 3, the “Lower Drug Costs Now Act of 2019,” which imposes government set price controls on prescription drugs. Members of Congress that refrain from cosponsoring this misguided legislation will receive credit for the Leadership component of the Chamber's “How They Voted” legislative scorecard.
WASHINGTON, D.C. – The U.S. Chamber of Commerce strongly opposes the introduction of a new House “Medicare for All” proposal because it would eliminate the private insurance coverage that more than 180 million Americans depend on for their healthcare needs.
WASHINGTON, D.C. - Following the first meeting of heads of state from the United States, Australia, India and Japan under the Quadrilateral Security Dialogue (‘Quad’) framework, the U.S. Chamber of Commerce issued the following statement:
The U.S. Chamber of Commerce’s Equality of Opportunity Initiative in partnership with the Chamber’s Discover & Deliver campaign, invites you to Equality of Opportunity in Action: Bridging the Racial Gap for COVID-19 Treatments and Vaccines on Tuesday, February 16 at 1:00 PM EST.
This Letter was sent to the President of the United States and to the Members of the United States Congress, on the Administration's "American Rescue Plan" and the Chamber's priorities for a bipartisan COVID-19 relief package.
This Hill Letter was sent to the Senate Committee on Homeland Security and Governmental Affairs, on the nomination of Alejandro Mayorkas to be Secretary of the Department of Homeland Security.
The latest on Operation Warp Speed from General Paul Ostrowski, director of supply, production and distribution for the program.
WASHINGTON, D.C. - U.S. Chamber of Commerce President Suzanne P. Clark today released the following statement regarding the Food and Drug Administration decision to grant an Emergency Use Authorization for Pfizer and BioNTech’s COVID-19 vaccine:
From shipping to staffing, the Chamber and its partners have the tools to save your business money and the solutions to help you run it more efficiently. Join the U.S. Chamber of Commerce today to start saving.
